PDS Biotechnology PDSB
NASDAQ PDSB
$0.75 +0.04 (+5.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Price to Earnings (2019)

Updated

PDS Biotechnology's Price to Earnings came in at 77.52 for Q2 2019, up 939.1% from the prior quarter.

Analysis

PDS Biotechnology (PDSB) Price to Earnings (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 PDS Biotechnology 41.94 Mn 41.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 77.52
Mar 31, 2019 7.46
API Access

PDS Biotechnology Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PDSB&period=max&api_key=YOUR_API_KEY